Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Muhonen

Neurological Surgery Orange, CA Medical Doctor

NPI 1801804810 CMS profile 671190

1010 West La Veta Ave, Suite 710, Orange, CA 92868

Open in the dashboard

General payments

$45,518

108 records reported · program years 2019–2025

Research payments

$13,975

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$444,440

1 holding reported · through program year 2025

Through program year 2025, Michael Muhonen of Orange, CA is reported in the CMS Open Payments database as having received $45,518 across 108 general payments and $13,975 in research payments paid to them. They also declared ownership or investment interests valued at $444,440 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $118 1
2024 General $219 6
2023 General $398 6
2022 General $2,689 23
2022 Research $1,625 2
2021 General $1,109 11
2021 Research $12,350 6
2020 General $8,956 19
2019 General $32,029 42
2019 Ownership $444,440 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Muhonen
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Michael Muhonen were reported at $118. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Michael Muhonen Neurological Surgery median Middle half National median
2019 $32,029 $582 $138–$3,006 $163
2020 $8,956 $294 $76–$2,174 $114
2021 $1,109 $387 $105–$2,432 $132
2022 $2,689 $542 $139–$2,989 $149
2023 $398 $534 $145–$2,697 $160
2024 $219 $574 $155–$3,046 $164
2025 $118 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Biogen, Inc. $31,549 28 payments
  2. Integra LifeSciences Corporation $9,943 31 payments
  3. Medtronic USA, Inc. $1,880 12 payments
  4. Medtronic, Inc. $938 13 payments
  5. Anuncia Medical Inc. $616 2 payments
  6. Ipsen Biopharmaceuticals, Inc $280 12 payments
  7. Osteomed LLC $130 1 payment
  8. Piramal Critical Care $78 3 payments
  9. Omniscient Neurotechnology America Ltd $20 1 payment
  10. Cook Medical LLC $19 1 payment
  11. Other $64 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $31,951 4 payments
  2. Travel and Lodging $7,779 13 payments
  3. Food and Beverage $4,358 89 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,300 1 payment
  5. Education $130 1 payment
Products named General payments · program years 2019–2025
  1. SPINRAZA $28,700 20 payments
  2. CUSA CLARITY $7,747 17 payments
  3. CODMAN HAKIM PRECISION VALVE $7,747 17 payments
  4. DURASEAL EXACT $7,747 17 payments
  5. CODMAN CERTAS $7,747 17 payments
  6. SYNCHROMED $1,676 8 payments
  7. ADVANCED WOUND CARE $1,426 4 payments
  8. Integra Recon-Skin And Wound $479 2 payments
  9. Integra Recon-Skin And Wound $479 2 payments
  10. PRIMATRIX $479 2 payments
  11. Other $4,588 95 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $13,975 8 payments

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$71,014

Of which drugs: $59,388

Medicare patients

32

Average age 50

Services billed

1,357

17 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
COPD 0%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, baclofen, 10 mg J0475 Office 19 388 $53,450

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SPINRAZA
  • Biogen, Inc. $169
$169 — —
DYSPORT
  • Ipsen Biopharmaceuticals, Inc $31
$31 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record